pivotal

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Design lock for ASIC microchip follows successful completion of in vivo preclinical and extensive bench testing Manufacturing of ASIC microchip…

4 months ago
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mgMenarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with…

5 months ago
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mgMenarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with…

5 months ago

UAE automotive aftermarket to reach US$1.91 billion by 2028, with SE Asian companies playing pivotal role

Southeast Asian (SEA) automotive companies are playing a pivotal role in the UAE expansion, contributing approximately 5% of the market…

6 months ago

UAE automotive aftermarket to reach US$1.91 billion by 2028, with SE Asian companies playing pivotal role

Southeast Asian (SEA) automotive companies are playing a pivotal role in the UAE expansion, contributing approximately 5% of the market…

6 months ago

UAE automotive aftermarket to reach US$1.91 billion by 2028, with SE Asian companies playing pivotal role

Southeast Asian (SEA) automotive companies are playing a pivotal role in the UAE expansion, contributing approximately 5% of the market…

6 months ago

UAE automotive aftermarket to reach US$1.91 billion by 2028, with SE Asian companies playing pivotal role

Southeast Asian (SEA) automotive companies are playing a pivotal role in the UAE expansion, contributing approximately 5% of the market…

6 months ago

UAE automotive aftermarket to reach US$1.91 billion by 2028, with SE Asian companies playing pivotal role

Southeast Asian (SEA) automotive companies are playing a pivotal role in the UAE expansion, contributing approximately 5% of the market…

6 months ago